Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New spanish app aims to help parents after Child's bone marrow transplant

NCT ID NCT06361173

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a Spanish-language app called BMT4me with 30 caregivers of children who had a bone marrow transplant. The goal was to see if the app is easy to use and acceptable for managing care after discharge. Caregivers used the app once and filled out a questionnaire to rate its usability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BMT4me app (Spanish version)
What this could lead to
If successful, this could provide a useful tool for Spanish-speaking caregivers to manage their child's post-transplant care at home.
What could go wrong
This is a small, completed usability test with only 30 participants. It does not measure health outcomes, so the app may not improve actual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Oct 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will recruit 30 self-identified Spanish speaking primary caregivers of children post-HCT at two institutions.

Ages

0 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Eligible caregivers must have children who: 1. Are 0-17 years old 2. Underwent HCT 3. Are planned for discharge prior to day 100 post-transplant Primary caregivers must: 1. Be Spanish speaking 2. Be ≥18 years old 3. Have a smartphone (iOS or Android) capable of downloading apps Exclusion Criteria: (a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bone marrow transplant are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10027, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, 43215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.